Overexpression of caspase-3 hepatocellular carcinomas

Rajendra Persad, Chen Liu, Tsung Teh Wu, Patrick S. Houlihan, Stanley R. Hamilton, Anna M. Diehl, Asif Rashid

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

Caspase-3 is a downstream effector cysteine protease in the apoptotic pathway. It is ubiquitously expressed in normal human tissues including the liver. Overexpression and loss of expression of caspase-3 has been reported in diverse human malignancies. However, expression of caspase-3 in hepatocellular carcinoma (HCC) has not been studied. Therefore, we studied its expression in four hepatoma cell lines and 22 HCCs by Western blot, and correlated the findings with in vitro caspase-3 activity and apoptosis. In addition, 47 surgically resected HCCs and 29 metastatic colorectal carcinomas were evaluated for caspase-3 expression by immunohistochemistry on formalin-fixed, paraffin-embedded tissue sections, and the staining intensity was correlated with the clinicopathological features. Caspase-3 overexpression was present in all four hepatoma cell lines, and 68% (15/22) of HCCs in comparison to the non-neoplastic liver parenchyma by Western blot, and in 52% (36/69) of HCCs by immunohistochemistry. Caspase-3 overexpression in HCCs by Western blot correlated with caspase-3 overexpression by immunohistochemistry (P=0.002), and in vitro caspase-3 activity (P=0.01). Caspase-3 overexpression in HCCs by immunohistochemistry was associated with serum ocfetoprotein (AFP) levels (P=0.01). In conclusion, caspase-3 is frequently overexpressed in HCCs and is associated with high serum levels of AFP.

Original languageEnglish (US)
Pages (from-to)861-867
Number of pages7
JournalModern Pathology
Volume17
Issue number7
DOIs
StatePublished - Jul 2004
Externally publishedYes

Fingerprint

Caspase 3
Hepatocellular Carcinoma
Immunohistochemistry
Western Blotting
Cell Line
Cysteine Proteases
Liver
Serum
Paraffin
Formaldehyde
Colorectal Neoplasms
Apoptosis
Staining and Labeling

Keywords

  • α-fetoprotein
  • Caspase-3
  • Hepatocellular carcinomas
  • Overexpression

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Persad, R., Liu, C., Wu, T. T., Houlihan, P. S., Hamilton, S. R., Diehl, A. M., & Rashid, A. (2004). Overexpression of caspase-3 hepatocellular carcinomas. Modern Pathology, 17(7), 861-867. https://doi.org/10.1038/modpathol.3800146

Overexpression of caspase-3 hepatocellular carcinomas. / Persad, Rajendra; Liu, Chen; Wu, Tsung Teh; Houlihan, Patrick S.; Hamilton, Stanley R.; Diehl, Anna M.; Rashid, Asif.

In: Modern Pathology, Vol. 17, No. 7, 07.2004, p. 861-867.

Research output: Contribution to journalArticle

Persad, R, Liu, C, Wu, TT, Houlihan, PS, Hamilton, SR, Diehl, AM & Rashid, A 2004, 'Overexpression of caspase-3 hepatocellular carcinomas', Modern Pathology, vol. 17, no. 7, pp. 861-867. https://doi.org/10.1038/modpathol.3800146
Persad R, Liu C, Wu TT, Houlihan PS, Hamilton SR, Diehl AM et al. Overexpression of caspase-3 hepatocellular carcinomas. Modern Pathology. 2004 Jul;17(7):861-867. https://doi.org/10.1038/modpathol.3800146
Persad, Rajendra ; Liu, Chen ; Wu, Tsung Teh ; Houlihan, Patrick S. ; Hamilton, Stanley R. ; Diehl, Anna M. ; Rashid, Asif. / Overexpression of caspase-3 hepatocellular carcinomas. In: Modern Pathology. 2004 ; Vol. 17, No. 7. pp. 861-867.
@article{e8ca4e0571214476ae3daa51186027d3,
title = "Overexpression of caspase-3 hepatocellular carcinomas",
abstract = "Caspase-3 is a downstream effector cysteine protease in the apoptotic pathway. It is ubiquitously expressed in normal human tissues including the liver. Overexpression and loss of expression of caspase-3 has been reported in diverse human malignancies. However, expression of caspase-3 in hepatocellular carcinoma (HCC) has not been studied. Therefore, we studied its expression in four hepatoma cell lines and 22 HCCs by Western blot, and correlated the findings with in vitro caspase-3 activity and apoptosis. In addition, 47 surgically resected HCCs and 29 metastatic colorectal carcinomas were evaluated for caspase-3 expression by immunohistochemistry on formalin-fixed, paraffin-embedded tissue sections, and the staining intensity was correlated with the clinicopathological features. Caspase-3 overexpression was present in all four hepatoma cell lines, and 68{\%} (15/22) of HCCs in comparison to the non-neoplastic liver parenchyma by Western blot, and in 52{\%} (36/69) of HCCs by immunohistochemistry. Caspase-3 overexpression in HCCs by Western blot correlated with caspase-3 overexpression by immunohistochemistry (P=0.002), and in vitro caspase-3 activity (P=0.01). Caspase-3 overexpression in HCCs by immunohistochemistry was associated with serum ocfetoprotein (AFP) levels (P=0.01). In conclusion, caspase-3 is frequently overexpressed in HCCs and is associated with high serum levels of AFP.",
keywords = "α-fetoprotein, Caspase-3, Hepatocellular carcinomas, Overexpression",
author = "Rajendra Persad and Chen Liu and Wu, {Tsung Teh} and Houlihan, {Patrick S.} and Hamilton, {Stanley R.} and Diehl, {Anna M.} and Asif Rashid",
year = "2004",
month = "7",
doi = "10.1038/modpathol.3800146",
language = "English (US)",
volume = "17",
pages = "861--867",
journal = "Modern Pathology",
issn = "0893-3952",
publisher = "Nature Publishing Group",
number = "7",

}

TY - JOUR

T1 - Overexpression of caspase-3 hepatocellular carcinomas

AU - Persad, Rajendra

AU - Liu, Chen

AU - Wu, Tsung Teh

AU - Houlihan, Patrick S.

AU - Hamilton, Stanley R.

AU - Diehl, Anna M.

AU - Rashid, Asif

PY - 2004/7

Y1 - 2004/7

N2 - Caspase-3 is a downstream effector cysteine protease in the apoptotic pathway. It is ubiquitously expressed in normal human tissues including the liver. Overexpression and loss of expression of caspase-3 has been reported in diverse human malignancies. However, expression of caspase-3 in hepatocellular carcinoma (HCC) has not been studied. Therefore, we studied its expression in four hepatoma cell lines and 22 HCCs by Western blot, and correlated the findings with in vitro caspase-3 activity and apoptosis. In addition, 47 surgically resected HCCs and 29 metastatic colorectal carcinomas were evaluated for caspase-3 expression by immunohistochemistry on formalin-fixed, paraffin-embedded tissue sections, and the staining intensity was correlated with the clinicopathological features. Caspase-3 overexpression was present in all four hepatoma cell lines, and 68% (15/22) of HCCs in comparison to the non-neoplastic liver parenchyma by Western blot, and in 52% (36/69) of HCCs by immunohistochemistry. Caspase-3 overexpression in HCCs by Western blot correlated with caspase-3 overexpression by immunohistochemistry (P=0.002), and in vitro caspase-3 activity (P=0.01). Caspase-3 overexpression in HCCs by immunohistochemistry was associated with serum ocfetoprotein (AFP) levels (P=0.01). In conclusion, caspase-3 is frequently overexpressed in HCCs and is associated with high serum levels of AFP.

AB - Caspase-3 is a downstream effector cysteine protease in the apoptotic pathway. It is ubiquitously expressed in normal human tissues including the liver. Overexpression and loss of expression of caspase-3 has been reported in diverse human malignancies. However, expression of caspase-3 in hepatocellular carcinoma (HCC) has not been studied. Therefore, we studied its expression in four hepatoma cell lines and 22 HCCs by Western blot, and correlated the findings with in vitro caspase-3 activity and apoptosis. In addition, 47 surgically resected HCCs and 29 metastatic colorectal carcinomas were evaluated for caspase-3 expression by immunohistochemistry on formalin-fixed, paraffin-embedded tissue sections, and the staining intensity was correlated with the clinicopathological features. Caspase-3 overexpression was present in all four hepatoma cell lines, and 68% (15/22) of HCCs in comparison to the non-neoplastic liver parenchyma by Western blot, and in 52% (36/69) of HCCs by immunohistochemistry. Caspase-3 overexpression in HCCs by Western blot correlated with caspase-3 overexpression by immunohistochemistry (P=0.002), and in vitro caspase-3 activity (P=0.01). Caspase-3 overexpression in HCCs by immunohistochemistry was associated with serum ocfetoprotein (AFP) levels (P=0.01). In conclusion, caspase-3 is frequently overexpressed in HCCs and is associated with high serum levels of AFP.

KW - α-fetoprotein

KW - Caspase-3

KW - Hepatocellular carcinomas

KW - Overexpression

UR - http://www.scopus.com/inward/record.url?scp=3042523719&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3042523719&partnerID=8YFLogxK

U2 - 10.1038/modpathol.3800146

DO - 10.1038/modpathol.3800146

M3 - Article

C2 - 15098015

AN - SCOPUS:3042523719

VL - 17

SP - 861

EP - 867

JO - Modern Pathology

JF - Modern Pathology

SN - 0893-3952

IS - 7

ER -